Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib in Perianal Fistulizing Crohn's Disease
NCT03077412Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2017
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of filgotinib in Crohn's disease, sponsored by Gilead Sciences. Started Apr 2017; status: completed.
02
Drugs
filgotinib
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03077412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03077412.